Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.
Press releases published on October 13, 2025
Nexford University Introduces Reimagined Bachelor of Business Administration (BBA) Built for Today’s Career Challenges
WASHINGTON, DC, UNITED STATES, October 13, 2025 /EINPresswire.com/ -- Making business education more affordable, flexible, and career-focused worldwide Nexford University, a next-generation accredited online university designed for modern learners, …
Murtons Projects Relocates Headquarters to Cape Town, Expands Roofing and Renovation Services Across Western Cape
Established Gauteng-based home improvement specialist brings 12+ years of expertise to Cape Town metropolitan area CAPE TOWN, SOUTH AFRICA, October 13, 2025 /EINPresswire.com/ -- Murtons Projects, a leading provider of roofing, waterproofing, painting, …
Global Africa Summit DC Kicks Off Tomorrow at Catholic University of America
Uniting Africa and Its Global Diaspora for Shared Prosperity WASHINGTON, DC, UNITED STATES, October 13, 2025 /EINPresswire.com/ -- The Africa Investment Network (AIN) will host the highly anticipated Global Africa Summit DC from October 14–15, 2025, at …
14th Africa CemenTrade Summit in Accra to Spotlight Low-Carbon Cement and Sustainable Innovation
ACCRA, GHANA, October 13, 2025 /EINPresswire.com/ -- Scheduled to convene on 29–30 October 2025 in Accra, Ghana, the 14th Africa CemenTrade Summit is supported by CBI Ghana with a site visit to their newly opened LC3 plant on 30 Oct. Also joining are …
Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
SAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Boundless Bio, (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified …
Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings
Translational data validate mechanism of first-in-concept extracellular-cleaving ADC micvotabart pelidotin (MICVO) MICVO combats solid tumors through three-pronged mechanism of action: direct tumor cell killing, bystander effect, and immunogenic cell death …
Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference
Preliminary data presented at the AACR-NCI-EORTC conference will provide insights into the potential of ZW191 in patients with advanced solid tumors, including ovarian cancer, endometrial cancer, and non-small cell lung cancer. Data from the Phase 1 trial …
Neutrolis Announces Late-Breaking Oral Presentation of Clinical Results at American College of Rheumatology Convergence 2025
CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Neutrolis Inc., a clinical-stage biotech company focused on targeting Neutrophil Extracellular Traps (NETs) to revolutionize the treatment of inflammatory disorders, announced today that a late-breaking …
XS.com Continua sua Expansão Estratégica e Conquista a Licença da SCA dos Emirados Árabes Unidos
BRAZIL, October 13, 2025 /Business News/ -- XS.com, a fornecedora global de serviços financeiros e fintech multiativos, tem o orgulho de anunciar que conquistou uma cobiçada licença regulatória da Securities …
Epista Launches Major Clinical Data Remediation Program with Global Pharma Leader
KING OF PRUSSIA, Pa., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Epista Life Science today announced one of the pharmaceutical industry's most comprehensive clinical data remediation programs, a multi-phase initiative spanning more than 800 studies, 43,000 study …
Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
CHICAGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has purchased an additional $300,000 worth of Ethereum ( …
Quanta Therapeutics Announces First Clinical Data Presentation for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, oral therapeutics for RAS-driven cancers, today announced …
BitMEX Launches Uptober Carnival: Win from a $1,000,000 Prize Pool
VICTORIA, Seychelles, Oct. 13, 2025 (GLOBE NEWSWIRE) -- BitMEX, one of the safest crypto exchanges, announced today the launch of its Uptober Carnival, allowing traders to compete for their share of a 1,000,000 USDT prize pool, iPhone 17 Pros, and up to $ …
BitMEX lanza Uptober Carnival: gane parte de un fondo de premios de 1.000.000 de dólares
VICTORIA, Seychelles, Oct. 13, 2025 (GLOBE NEWSWIRE) -- El día de hoy, BitMEX, una de las bolsas de criptomonedas más segura, anunció el lanzamiento de Uptober Carnival, que permitirá a los operadores competir por su parte de un fondo de premios de 1.000. …
Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108
PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn’s disease (FSCD) and ulcerative colitis (UC) to address significant unmet medical needs Carlsbad, CA, Oct. 13, 2025 (GLOBE NEWSWIRE) -- …
Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025
NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …